PACIFIC NORTHWEST NODE

PACIFIC NORTHWEST NODE

Principal Investigators:
Mary Hatch, PhD [email]
Addictions, Drug & Alcohol Institute, University of Washington
Seattle, WA

John Roll, PhD [email]
Elson S. Floyd College of Medicine
Washington State University
Spokane, WA
Node web site
NIDA web site

The Pacific Northwest Node (formerly the "Washington Node") joined the CTN in January 2001, and includes Washington and Alaska, with dissemination partners in Nevada and Oregon. Its CTPs provide a mix of settings including: urban and rural, private and public sector, in-patient/residential and outpatient, and drug free and methadone maintenance programs. The CTPs provide a wide range of treatment services to nearly 12,000 clients per year. All available services are also targeted to specific groups having special needs such as women, the elderly, Native Americans and Alaska Natives, dual disorder clients, homeless populations, and adolescent clients.

RRTCs: Addictions, Drug & Alcohol Institute, UW; Washington State University Program of Excellence in the Addictions.

PACIFIC NORTHWEST NODE PROTOCOL INVOLVEMENT
CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating the Diffusion of Innovation
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0015 Women's Treatment for Trauma and Substance Use Disorders
CTN-0017 HIV and HCV Intervention in Drug Treatment Settings
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)
CTN-0027-A-1 START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
CTN-0027-A-2 Retention of Suboxone Patients in START: Perspectives of Providers and Patients
CTN-0030 Prescription Opiate Abuse Treatment Study (POATS)
CTN-0030-A-1 Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
CTN-0031-A-1 An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers
CTN-0031-A-2 The Role of Alcohol Consumption Classifications of Alcohol Use Disorders: A Clinical Study
CTN-0033-Ot-3 Methamphetamine: Where Does It Fit in the Bigger Picture of Drug Use of American Indian and Alaska Native Communities and Treatment Seekers?
CTN-0034-Ot Developing Research Capacity and Culturally Appropriate Research Methods: Community-Based Participatory Research Manual for Collaborative Research in Drug Abuse for American Indians and Alaska Natives
CTN-0040-S Pattern of Alcohol Use and Alcohol-Related Diagnoses among Drug Abusing/Dependent Participants
CTN-0044 Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
CTN-0047 Screening Motivational Assessment and Referral to Treatment in Emergency Departments (SMART-ED): Evaluation of Screening, Brief Intervention, Referral to Treatment (SBIRT) and Booster Session for Drug Use Patients Presenting for Treatment in the Emergency Department
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
CTN-0050 Long Term Follow-Up of START Patients
CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)
CTN-0051-A-1 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study
CTN-0069 Opioid Use Disorder in the Emergency Department
CTN-0069-A-1 Retrospective Evaluation of Rapid Buprenorphine Induction in the Emergency Department for Opioid Use Disorder
CTN-0074 Primary Care Opioid Use Disorders (PROUD) Treatment Trial
CTN-0078-ot Knowledge of and Attitudes About Medication Assisted Treatment Within American Indian Communities
CTN-0080

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)
CTN-0082

Implementation Survey of PrEP and Opioid Use Related Services in STI Clinics and Community-Based Organizations (CBOs)
CTN-0082-A-1

COVID-19 Vaccine Readiness in People Who Use Substances In Community STI Clinics and Substance Use Intervention or Harm Reduction Programs In Eight Higher HIV Incidence Southeastern Cities

CTN-0085 Selection Bias Free Estimation of the Impact of Drug-Focused Twelve Step Mutual Help Groups Using the VA Database (NIH HEAL Initiative)
CTN-0087 Analyses of VA Databases to Examine Patient Characteristics Associated with Buprenorphine Termination During Opioid Use Disorder Treatment (NIH HEAL Initiative)
CTN-0091 Preventing and Identifying Opioid Use Disorder Using the Six Building Blocks (6BBs) for Improving Opioid Prescription Management (NIH HEAL Initiative)
CTN-0096 Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives (NIH HEAL Initiative)
CTN-0099 Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative)
CTN-0102 Rural Expansion of Medication Treatment for Opioid Use Disorder (NIH HEAL Initiative)
CTN-0106 Derivation and Validation of New Measurement-Based Care Tools Derived from the Brief Addiction Monitor (NIH HEAL Initiative)
CTN-0107 Peer Recovery Support: A Bridge to Treatment for Overdose Survivors (NIH HEAL Initiative)
CTN-0110 Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine For Methamphetamine Use Disorder (MURB)
CTN-0122 Comprehensive Meta-Analysis of CTN Treatment Outcomes by Race and Sex
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 9/2021 -- http://ctndisseminationlibrary.org/nodes/pnnode.htm
info@ctndisseminationlibrary.org